Long non‐coding RNAs and prostate cancer

Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led t...

Full description

Saved in:
Bibliographic Details
Published inCancer science Vol. 108; no. 11; pp. 2107 - 2114
Main Authors Misawa, Aya, Takayama, Ken‐ichi, Inoue, Satoshi
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.11.2017
John Wiley and Sons Inc
Subjects
Androgen
androgen receptor
Androgen receptors
Biomarkers
Biomarkers, Tumor - genetics
Carcinogenesis
Castration
castration resistant prostate cancer
Cell growth
Gene Expression Regulation, Neoplastic
Humans
Kinases
long non‐coding RNA
Male
Medical Overuse
Nucleotides
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - genetics
Prostatic Neoplasms - pathology
Review
Ribonucleic acid
RNA
RNA, Long Noncoding - genetics
Therapeutic applications
Unsolicited Review
prostate cancer
long non-coding RNA
androgen receptor
Androgen
castration resistant prostate cancer
Online AccessGet full text

Cover

Abstract Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration‐resistant prostate cancer. Long non‐coding (Lnc) RNAs modulate key cellular processes in normal physiology and diseases such as cancer. In this review, expression patterns of lncRNAs in prostate cancer and mechanisms which contribute to prostate carcinogenesis have been summarized.
AbstractList Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration‐resistant prostate cancer.
Long non-coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration-resistant prostate cancer.Long non-coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration-resistant prostate cancer.
Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration‐resistant prostate cancer. Long non‐coding (Lnc) RNAs modulate key cellular processes in normal physiology and diseases such as cancer. In this review, expression patterns of lncRNAs in prostate cancer and mechanisms which contribute to prostate carcinogenesis have been summarized.
Author Misawa, Aya
Inoue, Satoshi
Takayama, Ken‐ichi
AuthorAffiliation 1 Department of Anti‐Aging Medicine Graduate School of Medicine The University of Tokyo Tokyo Japan
2 Department of Functional Biogerontology Tokyo Metropolitan Institute of Gerontology Tokyo Japan
3 Division of Gene Regulation and Signal Transduction Research Center for Genomic Medicine Saitama Medical University Saitama Japan
AuthorAffiliation_xml – name: 3 Division of Gene Regulation and Signal Transduction Research Center for Genomic Medicine Saitama Medical University Saitama Japan
– name: 2 Department of Functional Biogerontology Tokyo Metropolitan Institute of Gerontology Tokyo Japan
– name: 1 Department of Anti‐Aging Medicine Graduate School of Medicine The University of Tokyo Tokyo Japan
Author_xml – sequence: 1
  givenname: Aya
  surname: Misawa
  fullname: Misawa, Aya
  organization: The University of Tokyo
– sequence: 2
  givenname: Ken‐ichi
  surname: Takayama
  fullname: Takayama, Ken‐ichi
  organization: Tokyo Metropolitan Institute of Gerontology
– sequence: 3
  givenname: Satoshi
  orcidid: 0000-0003-1247-3844
  surname: Inoue
  fullname: Inoue, Satoshi
  email: sinoue@tmig.or.jp
  organization: Saitama Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28796922$$D View this record in MEDLINE/PubMed
BookMark eNp1kctKAzEYhYMo2qoLX0AKblQYzX2SjVCKNygKXtYhk8loyjSpk1bpzkfwGX0SYy-iotkkId9_ODmnDVZ98BaAHQSPUFrHRscjRAjDK6CFCJVZDiFfnZ3zTEKCN0A7xgGEhFNJ18EGFrnkEuMWOOwH_9BJeu-vbyaULl1urrqxo33ZGTUhjvXYdoz2xjZbYK3SdbTbi30T3J-d3vUusv71-WWv288MIwRnrDAVxUZzXkBSCVZRBEuk84oWkkhji6oUAual5IhIUTBTGGYYLyEXtGCakk1wMtcdTYqhLY3140bXatS4oW6mKminfr5496gewrNinLOcySSwvxBowtPExrEaumhsXWtvwyQqJLFgCAtBErr3Cx2ESePT9xTGQuYYEyoStfvd0ZeVZYwJOJ4DJkUWG1sp41JyLnwadLVCUH0WpVJRalZUmjj4NbEU_YtdqL-42k7_B1Wvezuf-ADF1aE7
CitedBy_id crossref_primary_10_1002_biof_1486
crossref_primary_10_1016_j_jpha_2023_07_008
crossref_primary_10_3389_fcell_2021_753706
crossref_primary_10_1055_s_0041_1729780
crossref_primary_10_1186_s12885_021_08593_y
crossref_primary_10_1016_j_ebiom_2019_10_009
crossref_primary_10_1038_s41417_024_00834_z
crossref_primary_10_1038_s41419_018_0882_5
crossref_primary_10_18632_oncotarget_25048
crossref_primary_10_18632_aging_101664
crossref_primary_10_1016_j_rpor_2020_07_007
crossref_primary_10_1038_s41419_021_03455_8
crossref_primary_10_1042_BSR20181465
crossref_primary_10_3390_ijms24032472
crossref_primary_10_1002_cbin_12277
crossref_primary_10_1038_s41434_019_0108_1
crossref_primary_10_1186_s12920_020_00741_w
crossref_primary_10_1111_and_13897
crossref_primary_10_18632_aging_202997
crossref_primary_10_3389_fgene_2020_00062
crossref_primary_10_1016_j_canlet_2020_11_039
crossref_primary_10_1016_j_mgene_2019_100595
crossref_primary_10_1089_cbr_2019_3123
crossref_primary_10_3892_mmr_2018_9609
crossref_primary_10_1007_s00210_024_03736_x
crossref_primary_10_3892_mmr_2022_12747
crossref_primary_10_3892_ol_2019_10782
crossref_primary_10_1186_s12935_020_01371_z
crossref_primary_10_1016_j_prp_2023_154851
crossref_primary_10_25259_Cytojournal_36_2024
crossref_primary_10_18632_oncotarget_24307
crossref_primary_10_1016_j_canlet_2018_01_012
crossref_primary_10_3390_cancers12092382
crossref_primary_10_1016_j_lfs_2020_118035
crossref_primary_10_3389_fonc_2023_1123101
crossref_primary_10_1055_a_1745_8952
crossref_primary_10_1186_s12957_021_02232_3
crossref_primary_10_3390_biom11081214
crossref_primary_10_1007_s00432_020_03378_5
crossref_primary_10_3389_fonc_2024_1394292
crossref_primary_10_2217_epi_2023_0045
crossref_primary_10_32948_auo_2023_11_09
crossref_primary_10_1111_cas_14551
crossref_primary_10_3390_cancers15174357
crossref_primary_10_2147_CMAR_S271021
crossref_primary_10_2298_GENSR2203147M
crossref_primary_10_1038_s41391_021_00353_0
crossref_primary_10_1016_j_prp_2023_154729
crossref_primary_10_3390_cancers11010017
crossref_primary_10_1111_cpr_12678
crossref_primary_10_1016_j_cca_2020_11_027
crossref_primary_10_3389_fmolb_2022_939070
crossref_primary_10_1002_cam4_1556
crossref_primary_10_3389_fphar_2024_1442227
crossref_primary_10_3892_mmr_2018_9034
crossref_primary_10_1002_ctm2_1156
crossref_primary_10_32948_auo_2019_03_28
crossref_primary_10_1097_PPO_0000000000000688
crossref_primary_10_1002_jcb_29331
crossref_primary_10_3389_fonc_2020_593200
crossref_primary_10_3389_fonc_2019_00775
crossref_primary_10_1097_CAD_0000000000000882
crossref_primary_10_3389_fcell_2021_605686
crossref_primary_10_1080_15476286_2020_1755112
crossref_primary_10_1016_j_adcanc_2022_100067
crossref_primary_10_1038_s41598_022_20775_7
crossref_primary_10_1016_j_clbc_2021_05_003
crossref_primary_10_31832_smj_874417
crossref_primary_10_1002_pros_24494
crossref_primary_10_1016_j_biopha_2018_03_118
crossref_primary_10_1155_2021_5574130
crossref_primary_10_1080_14737159_2021_1996227
crossref_primary_10_1177_0300060520973137
crossref_primary_10_1155_2020_8812923
crossref_primary_10_3389_fcell_2021_641963
crossref_primary_10_1016_j_bbrep_2024_101832
crossref_primary_10_35995_tmj20220204
crossref_primary_10_1016_j_prp_2024_155746
crossref_primary_10_1016_j_urolonc_2020_06_003
crossref_primary_10_1155_2022_9292538
crossref_primary_10_1089_dna_2019_5247
crossref_primary_10_3389_fimmu_2020_00852
crossref_primary_10_2147_OTT_S267140
crossref_primary_10_1080_07853890_2023_2279748
crossref_primary_10_1042_BSR20211115
crossref_primary_10_1016_j_cellsig_2019_109422
crossref_primary_10_3389_fphar_2022_895696
crossref_primary_10_3390_ijms20164012
crossref_primary_10_1080_21655979_2021_2020397
crossref_primary_10_1186_s13046_019_1488_1
crossref_primary_10_1016_j_jsbmb_2022_106193
crossref_primary_10_3389_fonc_2021_770500
crossref_primary_10_1186_s12920_024_01851_5
crossref_primary_10_3390_cancers16142594
crossref_primary_10_3390_ijms222011242
Cites_doi 10.1038/onc.2010.436
10.1038/351153a0
10.1038/nature02871
10.1016/j.jmoldx.2014.06.009
10.1016/j.bbadis.2013.05.005
10.1016/j.neo.2014.11.006
10.1038/ng.375
10.1158/0008-5472.CAN-05-3014
10.1158/0008-5472.CAN-13-3159
10.1038/srep11516
10.1038/ng.2771
10.1038/emboj.2013.99
10.1186/1476-4598-14-3
10.1111/cas.12296
10.1126/science.1112014
10.1073/pnas.97.22.12216
10.1007/s13277-016-5012-3
10.18632/oncotarget.1769
10.1038/nature12451
10.1038/sj.onc.1209846
10.1016/j.neo.2014.09.001
10.1111/j.1349-7006.2010.01737.x
10.1158/2159-8290.CD-11-0209
10.1007/s12031-014-0488-z
10.1056/NEJMoa1311593
10.1158/0008-5472.CAN-09-0919
10.1038/ng0992-61
10.1038/nsmb.2591
10.1038/ng.3192
10.1111/febs.12902
10.1016/j.celrep.2015.08.069
10.1373/clinchem.2005.063289
10.1111/cas.12092
10.1200/JCO.2005.03.4777
10.1038/nm972
10.1186/s12943-015-0314-4
10.1038/sj.onc.1206928
10.1136/mp.53.6.320
10.1016/j.juro.2009.01.110
10.1016/j.cell.2009.02.006
10.1158/0008-5472.CAN-11-1021
10.1073/pnas.1415669112
10.1016/j.ajpath.2012.08.042
10.1126/scisignal.2000568
10.1002/cncr.25762
10.1172/JCI41824
10.1016/j.eururo.2013.09.046
10.1038/ng.2762
10.1146/annurev.med.59.053006.104707
10.1111/cas.12854
10.1074/jbc.M116.718536
10.1002/cncr.20518
10.18632/oncotarget.1846
10.1038/onc.2012.193
10.1002/0471142727.mb0710s92
10.1016/S1470-2045(14)71113-1
10.1038/sj.onc.1207069
10.1016/j.eururo.2015.12.003
10.1016/j.gdata.2014.10.020
10.18632/oncotarget.2691
10.1038/sj.onc.1201175
10.1158/0008-5472.CAN-11-1803
10.1016/j.ejca.2013.04.026
10.18632/oncotarget.5728
10.1038/nature08975
10.1002/pros.22952
10.1534/genetics.112.146704
10.1016/j.juro.2013.07.001
10.1177/147323001103900608
10.1038/nature12634
10.1155/2014/591703
10.1158/1541-7786.MCR-14-0257
10.1111/cas.13151
10.1038/onc.2014.144
10.1038/ncomms6383
10.1073/pnas.1507882112
10.1016/S0140-6736(14)61947-4
10.1016/j.bbi.2010.11.008
10.1016/j.eururo.2010.06.039
10.1093/nar/gkw995
10.1186/s13046-015-0123-z
ContentType Journal Article
Copyright 2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
– notice: 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
– notice: 2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1111/cas.13352
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Misawa et al
EISSN 1349-7006
EndPage 2114
ExternalDocumentID PMC5665759
28796922
10_1111_cas_13352
CAS13352
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Ministry of Education, Culture, Sports, Science and Technology, Japan
– fundername: Ministry of Health, Labor and Welfare, Japan
– fundername: NOVARTIS Foundation for the Promotion of Science, Japan
– fundername: Terumo Foundation for Life Sciences and Arts
– fundername: JSPS
  funderid: 15K15581; 15K15353
– fundername: National Institute of Biomedical Innovation, Japan
– fundername: JSPS
  grantid: 15K15581; 15K15353
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29B
2WC
31~
36B
3O-
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8FE
8FH
8UM
930
A01
A03
AAHHS
AAZKR
ABCQN
ABEML
ACCFJ
ACCMX
ACSCC
ACXQS
ADBBV
ADKYN
ADPDF
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFBPY
AFEBI
AFFNX
AFKRA
AFPKN
AFZJQ
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BFHJK
BHPHI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DIK
DR2
DU5
E3Z
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FIJ
GODZA
GROUPED_DOAJ
HCIFZ
HF~
HOLLA
HYE
HZI
HZ~
IAO
IHR
IPNFZ
ITC
IX1
J0M
K.9
K48
KQ8
LC2
LC3
LH4
LK8
LP6
LP7
LW6
M7P
MK4
N04
N05
N9A
O9-
OIG
OK1
OVD
P2P
P2X
P2Z
P4B
P4D
PIMPY
PROAC
Q11
ROL
RPM
RX1
SJN
SUPJJ
SV3
TEORI
UB1
W8V
WIN
WOW
WQJ
WRC
WXI
X7M
XG1
ZXP
~IA
~WT
7X7
88E
8FI
8FJ
AAFWJ
AAYXX
ABUWG
CITATION
FYUFA
HMCUK
M1P
PHGZM
PHGZT
PSQYO
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5332-5bcf42ca66b03f85f410d1a7f4b939cebfd8807d961398b5cbc5c56d0684b5a43
IEDL.DBID DR2
ISSN 1347-9032
1349-7006
IngestDate Thu Aug 21 18:36:26 EDT 2025
Sun Aug 24 04:08:39 EDT 2025
Wed Aug 13 09:24:36 EDT 2025
Thu Apr 03 07:00:16 EDT 2025
Tue Jul 01 01:31:02 EDT 2025
Thu Apr 24 22:56:16 EDT 2025
Wed Jan 22 16:38:15 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords prostate cancer
long non-coding RNA
androgen receptor
Androgen
castration resistant prostate cancer
Language English
License Attribution-NonCommercial-NoDerivs
http://creativecommons.org/licenses/by-nc-nd/4.0
2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5332-5bcf42ca66b03f85f410d1a7f4b939cebfd8807d961398b5cbc5c56d0684b5a43
Notes This work was supported by grants of P‐DIRECT and P‐CREATE from Ministry of Education, Culture, Sports, Science and Technology, Japan (SI); by grants (K.T. and S.I.) from JSPS (numbers 15K15581, 15K15353), Japan; by a grant from the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan (S.I.); by Grants‐in‐Aid (S.I.) from the Ministry of Health, Labor and Welfare, Japan; and grants from the Terumo Foundation for Life Sciences and Arts (K.T.) and the NOVARTIS Foundation for the Promotion of Science, Japan (K.T.).
Funding Information
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-1247-3844
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.13352
PMID 28796922
PQID 2289722348
PQPubID 4378882
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5665759
proquest_miscellaneous_1928512883
proquest_journals_2289722348
pubmed_primary_28796922
crossref_citationtrail_10_1111_cas_13352
crossref_primary_10_1111_cas_13352
wiley_primary_10_1111_cas_13352_CAS13352
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2017
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Tokyo
– name: Hoboken
PublicationTitle Cancer science
PublicationTitleAlternate Cancer Sci
PublicationYear 2017
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2015; 34
1991; 351
2009; 41
2010; 58
2011; 117
2016; 108
2016; 107
2015; 75
2004; 23
2013; 20
2010; 464
2017; 45
2016; 387
2014; 370
2016; 70
2016; 37
2005; 23
2014; 65
2012; 72
2015; 47
2014; 5
2014; 3
2006; 66
2011; 71
1997; 15
1999; 59
2000; 97
2000; 53
2014; 16
2014; 15
2005; 309
2011; 25
2014; 281
2010; 3
2013; 193
2014; 12
1992; 2
2007; 26
2013; 190
2004; 101
2015; 13
2015; 56
2009; 69
2015; 14
2015; 6
2006; 52
2015; 5
2011; 1
2013; 1832
2013; 49
2009; 181
2010
2009; 60
2013; 45
2013; 500
2013; 104
2013; 502
2011; 30
2010; 120
2014; 2014
2011; 39
2014; 111
2013; 182
2009; 136
2004; 431
2004; 10
2011; 102
2013; 32
2015; 112
2014; 74
2016; 291
2003; 22
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_60_1
e_1_2_7_83_1
e_1_2_7_17_1
e_1_2_7_62_1
e_1_2_7_81_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_64_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_66_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_68_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_49_1
e_1_2_7_28_1
e_1_2_7_73_1
e_1_2_7_50_1
e_1_2_7_71_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_52_1
e_1_2_7_77_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_54_1
e_1_2_7_75_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_56_1
e_1_2_7_37_1
e_1_2_7_58_1
e_1_2_7_79_1
e_1_2_7_39_1
e_1_2_7_6_1
e_1_2_7_4_1
e_1_2_7_80_1
e_1_2_7_8_1
Bussemakers MJ (e_1_2_7_19_1) 1999; 59
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_61_1
e_1_2_7_82_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_63_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_65_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_67_1
e_1_2_7_48_1
e_1_2_7_69_1
e_1_2_7_27_1
e_1_2_7_29_1
e_1_2_7_72_1
e_1_2_7_51_1
e_1_2_7_70_1
e_1_2_7_30_1
e_1_2_7_53_1
e_1_2_7_76_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_55_1
e_1_2_7_74_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_57_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_59_1
e_1_2_7_78_1
e_1_2_7_38_1
References_xml – volume: 14
  start-page: 46
  year: 2015
  article-title: The long non‐coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
  publication-title: Mol Cancer
– volume: 75
  start-page: 693
  year: 2015
  end-page: 705
  article-title: Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells
  publication-title: Prostate
– volume: 309
  start-page: 1559
  year: 2005
  end-page: 63
  article-title: The transcriptional landscape of the mammalian genome
  publication-title: Science
– volume: 74
  start-page: 1651
  year: 2014
  end-page: 60
  article-title: PCAT‐1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer
  publication-title: Cancer Res
– volume: 32
  start-page: 1616
  year: 2013
  end-page: 25
  article-title: HOTAIR is a negative prognostic factor and exhibits pro‐oncogenic activity in pancreatic cancer
  publication-title: Oncogene
– volume: 26
  start-page: 851
  year: 2007
  end-page: 8
  article-title: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas
  publication-title: Oncogene
– volume: 65
  start-page: 124
  year: 2014
  end-page: 37
  article-title: EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent‐update 2013
  publication-title: Eur Urol
– volume: 15
  start-page: 1469
  year: 2014
  end-page: 80
  article-title: RNA biomarkers associated with metastatic progression in prostate cancer: a multi‐institutional high‐throughput analysis of SChLAP1
  publication-title: Lancet Oncol
– volume: 16
  start-page: 615
  year: 2014
  end-page: 26
  article-title: Long noncoding RNAs as putative biomarkers for prostate cancer detection
  publication-title: J Mol Diagn
– volume: 49
  start-page: 2949
  year: 2013
  end-page: 59
  article-title: Long non‐coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma‐based biomarker for diagnosing prostate cancer
  publication-title: Eur J Cancer
– volume: 58
  start-page: 475
  year: 2010
  end-page: 81
  article-title: Performance of the prostate cancer antigen 3 (PCA3) gene and prostate‐specific antigen in prescreened men: exploring the value of PCA3 for a first‐line diagnostic test
  publication-title: Eur Urol
– volume: 111
  start-page: 18697
  year: 2014
  end-page: 702
  article-title: A long noncoding RNA connects c‐Myc to tumor metabolism
  publication-title: Proc Natl Acad Sci USA
– volume: 53
  start-page: 320
  year: 2000
  end-page: 3
  article-title: The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
  publication-title: Mol Pathol
– volume: 104
  start-page: 458
  year: 2013
  end-page: 64
  article-title: Long non‐coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival
  publication-title: Cancer Sci
– volume: 22
  start-page: 8031
  year: 2003
  end-page: 41
  article-title: MALAT‐1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early stage non‐small cell lung cancer
  publication-title: Oncogene
– volume: 59
  start-page: 5975
  year: 1999
  end-page: 9
  article-title: DD3: a new prostate‐specific gene, highly overexpressed in prostate cancer
  publication-title: Cancer Res
– volume: 5
  start-page: 5383
  year: 2014
  article-title: The oestrogen receptor alpha‐regulated lncRNA NEAT1 is a critical modulator of prostate cancer
  publication-title: Nat Commun
– volume: 107
  start-page: 149
  year: 2016
  end-page: 54
  article-title: Plasma level of metastasis‐associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma
  publication-title: Cancer Sci
– volume: 20
  start-page: 908
  year: 2013
  end-page: 13
  article-title: Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer
  publication-title: Nat Struct Mol Biol
– volume: 97
  start-page: 12216
  year: 2000
  end-page: 21
  article-title: PCGEM1, a prostate‐specific gene, is overexpressed in prostate cancer
  publication-title: Proc Natl Acad Sci USA
– volume: 1832
  start-page: 1613
  year: 2013
  end-page: 23
  article-title: Long non‐coding RNA GAS5 regulates apoptosis in prostate cancer cell lines
  publication-title: Biochim Biophys Acta
– volume: 45
  start-page: D737
  issue: D1
  year: 2017
  end-page: 43
  article-title: Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals
  publication-title: Nucleic Acids Res
– volume: 69
  start-page: 8141
  year: 2009
  end-page: 9
  article-title: Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens
  publication-title: Cancer Res
– volume: 23
  start-page: 605
  year: 2004
  end-page: 11
  article-title: Elevated expression of PCGEM1, a prostate‐specific gene with cell growth‐promoting function, is associated with high‐risk prostate cancer patients
  publication-title: Oncogene
– volume: 12
  start-page: 1081
  year: 2014
  end-page: 7
  article-title: The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
  publication-title: Mol Cancer Res
– volume: 70
  start-page: 549
  year: 2016
  end-page: 52
  article-title: Overexpression of the long non‐coding RNA SChLAP1 independently predicts lethal prostate cancer
  publication-title: Eur Urol
– volume: 431
  start-page: 350
  year: 2004
  end-page: 5
  article-title: The functions of animal microRNAs
  publication-title: Nature
– volume: 10
  start-page: 33
  year: 2004
  end-page: 9
  article-title: Molecular determinants of resistance to antiandrogen therapy
  publication-title: Nat Med
– volume: 47
  start-page: 199
  year: 2015
  end-page: 208
  article-title: The landscape of long noncoding RNAs in the human transcriptome
  publication-title: Nat Genet
– volume: 6
  start-page: 41045
  year: 2015
  end-page: 55
  article-title: LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration‐resistant prostate cancer
  publication-title: Oncotarget
– volume: 181
  start-page: 2508
  year: 2009
  end-page: 13
  article-title: A duplex quantitative polymerase chain reaction assay based on quantification of alpha‐methylacyl‐CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer
  publication-title: J Urol
– volume: 387
  start-page: 70
  year: 2016
  end-page: 82
  article-title: Prostate cancer
  publication-title: Lancet
– volume: 16
  start-page: 900
  year: 2014
  end-page: 8
  article-title: The long non‐coding RNA PCAT‐1 promotes prostate cancer cell proliferation through cMyc
  publication-title: Neoplasia
– volume: 13
  start-page: 209
  year: 2015
  end-page: 21
  article-title: LncRNA HOTAIR enhances the androgen‐receptor‐mediated transcriptional program and drives castration‐resistant prostate cancer
  publication-title: Cell Rep
– volume: 3
  start-page: 4
  year: 2014
  end-page: 5
  article-title: Expression‐profiling of apoptosis induced by ablation of the long ncRNA TRPM2‐AS in prostate cancer cell
  publication-title: Genom Data
– volume: 14
  start-page: 3
  year: 2015
  article-title: Identification of the long non‐coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma
  publication-title: Mol Cancer
– volume: 72
  start-page: 1126
  year: 2012
  end-page: 36
  article-title: Upregulation of miR‐196a and HOTAIR drive malignant character in gastrointestinal stromal tumors
  publication-title: Cancer Res
– volume: 193
  start-page: 651
  year: 2013
  end-page: 69
  article-title: Long noncoding RNAs: past, present, and future
  publication-title: Genetics
– volume: 102
  start-page: 245
  year: 2011
  end-page: 52
  article-title: Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
  publication-title: Cancer Sci
– volume: 108
  start-page: 373
  year: 2016
  end-page: 9
  article-title: Androgen‐induced lncRNA POTEF‐AS1 regulates apoptosis related pathway to facilitate cell survival in prostate cancer cells
  publication-title: Cancer Sci
– volume: 464
  start-page: 1071
  year: 2010
  end-page: 6
  article-title: Long non‐coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
  publication-title: Nature
– volume: 15
  start-page: 169
  year: 1997
  end-page: 77
  article-title: The expression of the imprinted genes H19 and IGF‐2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?
  publication-title: Oncogene
– year: 2010
  article-title: Single molecule sequencing with a HeliScope genetic analysis system
  publication-title: Curr Protoc Mol Biol
– volume: 281
  start-page: 3766
  year: 2014
  end-page: 75
  article-title: lncRNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFB1
  publication-title: FEBS J
– volume: 45
  start-page: 1127
  year: 2013
  end-page: 33
  article-title: Emerging landscape of oncogenic signatures across human cancers
  publication-title: Nat Genet
– volume: 1
  start-page: 391
  year: 2011
  end-page: 407
  article-title: The emergence of lncRNAs in cancer biology
  publication-title: Cancer Discov
– volume: 25
  start-page: 468
  year: 2011
  end-page: 82
  article-title: Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity
  publication-title: Brain Behav Immun
– volume: 2
  start-page: 61
  year: 1992
  end-page: 5
  article-title: Physical linkage of two mammalian imprinted genes, H19 and insulin‐like growth factor 2
  publication-title: Nat Genet
– volume: 71
  start-page: 6320
  year: 2011
  end-page: 6
  article-title: Long noncoding RNA HOTAIR regulates polycomb‐dependent chromatin modification and is associated with poor prognosis in colorectal cancers
  publication-title: Cancer Res
– volume: 52
  start-page: 1089
  year: 2006
  end-page: 95
  article-title: APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer
  publication-title: Clin Chem
– volume: 502
  start-page: 333
  year: 2013
  end-page: 9
  article-title: Mutational landscape and significance across 12 major cancer types
  publication-title: Nature
– volume: 30
  start-page: 619
  year: 2011
  end-page: 30
  article-title: Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome‐wide androgen receptor signaling in prostate cancer cells
  publication-title: Oncogene
– volume: 104
  start-page: 1675
  year: 2013
  end-page: 82
  article-title: HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF‐1 expression and activates Wnt pathway
  publication-title: Cancer Sci
– volume: 60
  start-page: 167
  year: 2009
  end-page: 79
  article-title: MicroRNAs in cancer
  publication-title: Annu Rev Med
– volume: 291
  start-page: 17861
  year: 2016
  end-page: 80
  article-title: Androgen‐induced long noncoding RNA (lncRNA) SOCS2‐AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells
  publication-title: J Biol Chem
– volume: 56
  start-page: 623
  year: 2015
  end-page: 30
  article-title: Expression and functional role of reprogramming‐related long noncoding RNA (lincRNA‐ROR) in glioma
  publication-title: J Mol Neurosci
– volume: 34
  start-page: 2094
  year: 2015
  end-page: 102
  article-title: Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer
  publication-title: Oncogene
– volume: 351
  start-page: 153
  year: 1991
  end-page: 5
  article-title: Parental imprinting of the mouse H19 gene
  publication-title: Nature
– volume: 41
  start-page: 553
  year: 2009
  end-page: 62
  article-title: The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line
  publication-title: Nat Genet
– volume: 66
  start-page: 52
  year: 2006
  end-page: 6
  article-title: POTE paralogs are induced and differentially expressed in many cancers
  publication-title: Cancer Res
– volume: 5
  start-page: 11091
  year: 2014
  end-page: 102
  article-title: Development and prospective multicenter evaluation of the long noncoding RNA MALAT‐1 as a diagnostic urinary biomarker for prostate cancer
  publication-title: Oncotarget
– volume: 2014
  start-page: 591703
  year: 2014
  article-title: Noncoding RNAs as novel biomarkers in prostate cancer
  publication-title: Biomed Res Int
– volume: 5
  start-page: 764
  year: 2014
  end-page: 74
  article-title: Identification of a long non‐coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
  publication-title: Oncotarget
– volume: 39
  start-page: 2119
  year: 2011
  end-page: 28
  article-title: Large intervening non‐coding RNA HOTAIR is associated with hepatocellular carcinoma progression
  publication-title: J Int Med Res
– volume: 32
  start-page: 1665
  year: 2013
  end-page: 80
  article-title: Androgen‐responsive long noncoding RNA CTBP1‐AS promotes prostate cancer
  publication-title: EMBO J
– volume: 120
  start-page: 2715
  year: 2010
  end-page: 30
  article-title: Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
  publication-title: J Clin Invest
– volume: 45
  start-page: 1392
  year: 2013
  end-page: 8
  article-title: The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
  publication-title: Nat Genet
– volume: 136
  start-page: 629
  year: 2009
  end-page: 41
  article-title: Evolution and functions of long noncoding RNAs
  publication-title: Cell
– volume: 101
  start-page: 1345
  year: 2004
  end-page: 56
  article-title: Up‐regulation of Wnt‐1 and beta‐catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications
  publication-title: Cancer
– volume: 37
  start-page: 11339
  year: 2016
  end-page: 48
  article-title: PCA3 long noncoding RNA modulates the expression of key cancer‐related genes in LNCaP prostate cancer cells
  publication-title: Tumour Biol
– volume: 370
  start-page: 932
  year: 2014
  end-page: 42
  article-title: Radical prostatectomy or watchful waiting in early prostate cancer
  publication-title: N Engl J Med
– volume: 190
  start-page: 2278
  year: 2013
  end-page: 87
  article-title: Long noncoding RNA MALAT‐1 is a new potential therapeutic target for castration resistant prostate cancer
  publication-title: J Urol
– volume: 5
  start-page: 1434
  year: 2014
  end-page: 8
  article-title: The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
  publication-title: Oncotarget
– volume: 5
  start-page: 11516
  year: 2015
  article-title: Identification of the long non‐coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer
  publication-title: Sci Rep
– volume: 16
  start-page: 1121
  year: 2014
  end-page: 7
  article-title: A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer
  publication-title: Neoplasia
– volume: 182
  start-page: 64
  year: 2013
  end-page: 70
  article-title: Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma
  publication-title: Am J Pathol
– volume: 112
  start-page: 8403
  year: 2015
  end-page: 8
  article-title: PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3
  publication-title: Proc Natl Acad Sci USA
– volume: 500
  start-page: 598
  year: 2013
  end-page: 602
  article-title: lncRNA‐dependent mechanisms of androgen‐receptor‐regulated gene activation programs
  publication-title: Nature
– volume: 34
  start-page: 7
  year: 2015
  article-title: Up‐regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma
  publication-title: J Exp Clin Cancer Res
– volume: 23
  start-page: 8253
  year: 2005
  end-page: 61
  article-title: Biology of progressive, castration‐resistant prostate cancer: directed therapies targeting the androgen‐receptor signaling axis
  publication-title: J Clin Oncol
– volume: 117
  start-page: 2077
  year: 2011
  end-page: 85
  article-title: Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration‐resistant nonmetastatic prostate cancer
  publication-title: Cancer
– volume: 3
  start-page: ra8
  year: 2010
  article-title: Noncoding RNA gas5 is a growth arrest‐ and starvation‐associated repressor of the glucocorticoid receptor
  publication-title: Sci Signal
– ident: e_1_2_7_49_1
  doi: 10.1038/onc.2010.436
– ident: e_1_2_7_66_1
  doi: 10.1038/351153a0
– ident: e_1_2_7_2_1
  doi: 10.1038/nature02871
– ident: e_1_2_7_26_1
  doi: 10.1016/j.jmoldx.2014.06.009
– ident: e_1_2_7_64_1
  doi: 10.1016/j.bbadis.2013.05.005
– ident: e_1_2_7_24_1
  doi: 10.1016/j.neo.2014.11.006
– ident: e_1_2_7_80_1
  doi: 10.1038/ng.375
– ident: e_1_2_7_62_1
  doi: 10.1158/0008-5472.CAN-05-3014
– ident: e_1_2_7_39_1
  doi: 10.1158/0008-5472.CAN-13-3159
– ident: e_1_2_7_79_1
  doi: 10.1038/srep11516
– ident: e_1_2_7_22_1
  doi: 10.1038/ng.2771
– ident: e_1_2_7_50_1
  doi: 10.1038/emboj.2013.99
– ident: e_1_2_7_78_1
  doi: 10.1186/1476-4598-14-3
– ident: e_1_2_7_58_1
  doi: 10.1111/cas.12296
– ident: e_1_2_7_81_1
  doi: 10.1126/science.1112014
– ident: e_1_2_7_36_1
  doi: 10.1073/pnas.97.22.12216
– ident: e_1_2_7_20_1
  doi: 10.1007/s13277-016-5012-3
– ident: e_1_2_7_43_1
  doi: 10.18632/oncotarget.1769
– ident: e_1_2_7_46_1
  doi: 10.1038/nature12451
– ident: e_1_2_7_28_1
  doi: 10.1038/sj.onc.1209846
– ident: e_1_2_7_40_1
  doi: 10.1016/j.neo.2014.09.001
– ident: e_1_2_7_45_1
  doi: 10.1111/j.1349-7006.2010.01737.x
– ident: e_1_2_7_9_1
  doi: 10.1158/2159-8290.CD-11-0209
– ident: e_1_2_7_5_1
  doi: 10.1007/s12031-014-0488-z
– ident: e_1_2_7_12_1
  doi: 10.1056/NEJMoa1311593
– ident: e_1_2_7_17_1
  doi: 10.1158/0008-5472.CAN-09-0919
– ident: e_1_2_7_67_1
  doi: 10.1038/ng0992-61
– ident: e_1_2_7_42_1
  doi: 10.1038/nsmb.2591
– ident: e_1_2_7_10_1
  doi: 10.1038/ng.3192
– ident: e_1_2_7_70_1
  doi: 10.1111/febs.12902
– ident: e_1_2_7_59_1
  doi: 10.1016/j.celrep.2015.08.069
– ident: e_1_2_7_73_1
  doi: 10.1373/clinchem.2005.063289
– ident: e_1_2_7_57_1
  doi: 10.1111/cas.12092
– ident: e_1_2_7_13_1
  doi: 10.1200/JCO.2005.03.4777
– ident: e_1_2_7_15_1
  doi: 10.1038/nm972
– ident: e_1_2_7_48_1
  doi: 10.1186/s12943-015-0314-4
– ident: e_1_2_7_27_1
  doi: 10.1038/sj.onc.1206928
– ident: e_1_2_7_69_1
  doi: 10.1136/mp.53.6.320
– ident: e_1_2_7_74_1
  doi: 10.1016/j.juro.2009.01.110
– ident: e_1_2_7_71_1
  doi: 10.1016/j.cell.2009.02.006
– ident: e_1_2_7_52_1
  doi: 10.1158/0008-5472.CAN-11-1021
– ident: e_1_2_7_38_1
  doi: 10.1073/pnas.1415669112
– ident: e_1_2_7_55_1
  doi: 10.1016/j.ajpath.2012.08.042
– ident: e_1_2_7_63_1
  doi: 10.1126/scisignal.2000568
– ident: e_1_2_7_14_1
  doi: 10.1002/cncr.25762
– ident: e_1_2_7_18_1
  doi: 10.1172/JCI41824
– ident: e_1_2_7_75_1
  doi: 10.1016/j.eururo.2013.09.046
– ident: e_1_2_7_8_1
  doi: 10.1038/ng.2762
– ident: e_1_2_7_3_1
  doi: 10.1146/annurev.med.59.053006.104707
– ident: e_1_2_7_29_1
  doi: 10.1111/cas.12854
– ident: e_1_2_7_60_1
  doi: 10.1074/jbc.M116.718536
– ident: e_1_2_7_16_1
  doi: 10.1002/cncr.20518
– ident: e_1_2_7_47_1
  doi: 10.18632/oncotarget.1846
– ident: e_1_2_7_56_1
  doi: 10.1038/onc.2012.193
– ident: e_1_2_7_83_1
  doi: 10.1002/0471142727.mb0710s92
– ident: e_1_2_7_23_1
  doi: 10.1016/S1470-2045(14)71113-1
– ident: e_1_2_7_37_1
  doi: 10.1038/sj.onc.1207069
– ident: e_1_2_7_25_1
  doi: 10.1016/j.eururo.2015.12.003
– ident: e_1_2_7_34_1
  doi: 10.1016/j.gdata.2014.10.020
– ident: e_1_2_7_31_1
  doi: 10.18632/oncotarget.2691
– ident: e_1_2_7_68_1
  doi: 10.1038/sj.onc.1201175
– volume: 59
  start-page: 5975
  year: 1999
  ident: e_1_2_7_19_1
  article-title: DD3: a new prostate‐specific gene, highly overexpressed in prostate cancer
  publication-title: Cancer Res
– ident: e_1_2_7_54_1
  doi: 10.1158/0008-5472.CAN-11-1803
– ident: e_1_2_7_77_1
  doi: 10.1016/j.ejca.2013.04.026
– ident: e_1_2_7_32_1
  doi: 10.18632/oncotarget.5728
– ident: e_1_2_7_51_1
  doi: 10.1038/nature08975
– ident: e_1_2_7_65_1
  doi: 10.1002/pros.22952
– ident: e_1_2_7_72_1
  doi: 10.1534/genetics.112.146704
– ident: e_1_2_7_30_1
  doi: 10.1016/j.juro.2013.07.001
– ident: e_1_2_7_53_1
  doi: 10.1177/147323001103900608
– ident: e_1_2_7_7_1
  doi: 10.1038/nature12634
– ident: e_1_2_7_41_1
  doi: 10.1155/2014/591703
– ident: e_1_2_7_44_1
  doi: 10.1158/1541-7786.MCR-14-0257
– ident: e_1_2_7_61_1
  doi: 10.1111/cas.13151
– ident: e_1_2_7_33_1
  doi: 10.1038/onc.2014.144
– ident: e_1_2_7_35_1
  doi: 10.1038/ncomms6383
– ident: e_1_2_7_21_1
  doi: 10.1073/pnas.1507882112
– ident: e_1_2_7_11_1
  doi: 10.1016/S0140-6736(14)61947-4
– ident: e_1_2_7_4_1
  doi: 10.1016/j.bbi.2010.11.008
– ident: e_1_2_7_76_1
  doi: 10.1016/j.eururo.2010.06.039
– ident: e_1_2_7_82_1
  doi: 10.1093/nar/gkw995
– ident: e_1_2_7_6_1
  doi: 10.1186/s13046-015-0123-z
SSID ssj0036494
Score 2.5359077
SecondaryResourceType review_article
Snippet Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been...
Long non-coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2107
SubjectTerms Androgen
androgen receptor
Androgen receptors
Biomarkers
Biomarkers, Tumor - genetics
Carcinogenesis
Castration
castration resistant prostate cancer
Cell growth
Gene Expression Regulation, Neoplastic
Humans
Kinases
long non‐coding RNA
Male
Medical Overuse
Nucleotides
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - genetics
Prostatic Neoplasms - pathology
Review
Ribonucleic acid
RNA
RNA, Long Noncoding - genetics
Therapeutic applications
Unsolicited Review
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-QLyIb-uLKh5EKLZJmjQnWUQRUQ_qwt5K86gK0l1317s_wd_oL3GSZusuq94KmTbNTJL5JpOZQeiIEKITY0yEcVJGNNMykobzKFYZpcIWWnBx3Ld37KpNrztpxx-4Dfy1ytGe6DZq3VX2jPwUg2XAQZfR7Kz3FtmqUda76ktozKJ5m7rMzmreaQwuwqioi9pSHomYYJ9ZyN7ksQXFkjreaFwfTYHM6buS4xjWKaHLZbTk0WPYqsW9gmZMtYoWbr1_fA2d3HSrpxAs-q-PT9W1aim8v2sNwqLSYc_GdwCyDJUVdH8dtS8vHs-vIl8NIVIAycBilKqkWBWMyZiUWVrSJNZJwUsqBRHKyFLDWuRagIIWmUyVVKlKmY5ZRmVaULKB5qB_s4VCICCSiSLBJVhDKhOKyVQD1uNJqblgAToe8SRXPlW4rVjxmo9MBmBf7tgXoMOGtFfnx_iNaHfE2NwvkUH-I9AAHTTNMLmtx6KoTPcd3hYYEKEtiBygzVoOTS9g6gkmMHycT0ioIbCJsydbqpdnl0A7de4mAcN0svz7x_Pz1oN72P5_BDtoEVt172IUd9HcsP9u9gCsDOW-m5HftjbmiQ
  priority: 102
  providerName: ProQuest
Title Long non‐coding RNAs and prostate cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.13352
https://www.ncbi.nlm.nih.gov/pubmed/28796922
https://www.proquest.com/docview/2289722348
https://www.proquest.com/docview/1928512883
https://pubmed.ncbi.nlm.nih.gov/PMC5665759
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bSxwxFD5YC6Uv1mpbt12XUXwohZGZJJNM8GldFCl1kbXCPhSGyWWqKLPi7r70qT_B3-gv6UnmgqsWxJdhICeTnElO8p3kXAB2KKUmttaGhMRFyFKjQmWFCCOdMiZdogXvx3085Edn7Ps4GS_BXuMLU8WHaA_cnGT49doJeK6m94TcpQSLnccQrr_OVssBolEbOopyJquEtkyEMqKkjirkrHjamot70SOA-dhO8j5-9RvQ4Tv41XS9sju53J3P1K7-8yCq4wt5W4WVGpgG_WomvYclW67Bm-P66n0dvv2YlL-DclLe_b3VE7fjBaNhfxrkpQmunesIgtZAuzl08wHODg9-Do7COtFCqBHtoTKqdMGIzjlXES3SpGBxZOJcFExJKrVVhUExF0bi3i9TlWilE51wE_GUqSRn9CMsY_t2AwIkoIrLPCYFKlo6lZqrxCCMFHFhhOQd-Nr88kzXUchdMoyrrNFGkPfM896B7Zb0ugq98RRRtxm3rJa-aUZQixSIe1jaga22GOXGXYbkpZ3MsbYkCDZdruUOfKqGuW0FtUjJJcGPi4UJ0BK4mNyLJeXFuY_NnfibLIls-vH9f8ezQf_Uv3x-PukXeEscqvCukF1Ynt3M7SZiopnqwSvCTvApxqIHr_cPhiejnj9f6Hmx-Acn7gq6
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NTtwwEB4BlUovVX_ptrSkVZGqShGJ7djxoapWFLTA7h4KSHsL8U8AqUq2LKjqrY_Ak_BQfZKOnR9AQG_cItmx45mx55uMZwbgI6XUxNbakJC4CFlqVKisEGGkU8akK7Tg47hHYz7YZ9uTZDIHF20sjLtW2Z6J_qA2lXb_yNcIWgYCdRlLv05_hq5qlPOutiU0arHYsb9_ock2-7L1Dfm7Ssjmxt76IGyqCoQaoQ1aXkoXjOiccxXRIk0KFkcmzkXBlKRSW1UYlGlhJCo6mapEK53ohJuIp0wlOaM47jw8QMUbOWNPTDoDj3Im6yK6TIQyoqTJZORuDrkCZnEd33RV_90AtTfvZl7FzF7pbT6Bxw1aDfq1eD2FOVs-g4ejxh__HD4Pq_IwKKvy759zXTk1GHwf92dBXppg6uJJEMkG2gnWyQvYvxc6vYQFnN--ggA7UMVlHpMCrS-dSs1VYhBbirgwQvIefGppkukmNbmrkPEja00UJF_mydeDD13XaZ2P47ZOyy1hs2ZLzrJLAerB-64ZN5PzkOSlrc7wbUkQgboCzD1YqvnQzYKmpeSS4ODiGoe6Di5R9_WW8vjIJ-xOvHtL4jI9L-_-8Gy9v-sfXv9_BSuwONgbDbPh1njnDTwiDmr4-MhlWDg9ObNvESidqndeOgM4uO_t8A-0xiOD
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fT9UwFD_BS0J8IYp_uAo4jSbGZGFru3Z9IOYK3IDADUFJeBvrPyUh25ULMb75Efw8fhw_CafddoGgvvG2pF27nj89v7P2nAPwmlJqUmttTEjqYpYbFSsrRJzonDHpCy2EOO69Ed86ZB-PsqMZ-N3Fwvhrld2eGDZqU2v_j3yVoGcg0JaxfNW11yL2N4bvx99iX0HKn7R25TQaEdmxP76j-zZZ295AXr8hZLj5eX0rbisMxBphDnphSjtGdMm5SqjLM8fSxKSlcExJKrVVzqB8CyPR6MlcZVrpTGfcJDxnKisZxXHvwazwXlEPZj9sjvYPOjtAOZNNSV0mYplQ0uY18veIfDmztIl2um4Nb0Hc2zc1ryPoYAKHD2C-xa7RoBG2hzBjqwWY22tP5x_Bu926-hJVdfXn5y9de6MYHYwGk6isTDT20SWIayPtxezsMRzeCaWeQA_nt4sQYQequCxT4tAX07nUXGUGkaZInRGS9-FtR5NCt4nKfb2M06JzWJB8RSBfH15Nu46b7Bx_67TUEbZoFXRSXIlTH15Om1G1_HlJWdn6At-WBPGoL8fch6cNH6azoKMpuSQ4uLjBoWkHn7b7Zkt18jWk787CYZfEZQZe_vvDi_XBp_Dw7P8reAFzqArF7vZo5zncJx53hGDJJeidn13YZURN52qlFc8Iju9aIy4BQ8kpHg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+non%E2%80%90coding+RNAs+and+prostate+cancer&rft.jtitle=Cancer+science&rft.au=Misawa%2C+Aya&rft.au=Takayama%2C+Ken%E2%80%90ichi&rft.au=Inoue%2C+Satoshi&rft.date=2017-11-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=108&rft.issue=11&rft.spage=2107&rft.epage=2114&rft_id=info:doi/10.1111%2Fcas.13352&rft_id=info%3Apmid%2F28796922&rft.externalDocID=PMC5665759
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon